C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) C07K 16/46 (2006.01)
Patent
CA 2438682
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor or an anti-receptor antibody, have proven usefulness in both basic research and as therapeutics. The present invention provides antibodies that bind two tumor necrosis factor receptor family members: the transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor, and the B-cellmaturation (BCMA) receptor.
Des molécules qui gênent la liaison d'un récepteur de facteur de nécrose tumorale avec son ligand, tel qu'un récepteur soluble ou un anticorps anti-récepteur, ont prouvé leur utilité, à la fois dans la recherche fondamentale et dans la thérapeutique. L'invention concerne des anticorps qui lient deux membres de la famille des récepteurs de facteur de nécrose tumorale: le récepteur TACI, activateur transmembranaire modulant le calcium et interagissant sur le ligand de cyclophiline, et le récepteur BCMA de maturation de cellule B.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Zymogenetics Inc.
LandOfFree
Antibodies that bind both bcma and taci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that bind both bcma and taci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind both bcma and taci will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846874